| Primary |
| Hiv Infection |
46.9% |
| Product Used For Unknown Indication |
18.2% |
| Drug Use For Unknown Indication |
9.5% |
| Drug Exposure During Pregnancy |
9.2% |
| Antiretroviral Therapy |
4.5% |
| Maternal Exposure Timing Unspecified |
3.5% |
| Hypertension |
0.9% |
| Hepatitis C |
0.8% |
| Tuberculosis |
0.8% |
| Prophylaxis |
0.8% |
| Systemic Antiviral Treatment |
0.8% |
| Hiv Test Positive |
0.6% |
| Antiviral Treatment |
0.6% |
| Acquired Immunodeficiency Syndrome |
0.5% |
| Depression |
0.5% |
| Maternal Exposure During Pregnancy |
0.5% |
| Hyperlipidaemia |
0.4% |
| Burkitt's Lymphoma |
0.4% |
| Mycobacterium Avium Complex Infection |
0.4% |
| Routine Health Maintenance |
0.4% |
|
| Abortion Spontaneous |
11.5% |
| Haematotoxicity |
9.1% |
| Abortion Induced |
7.9% |
| Premature Baby |
6.3% |
| Drug Interaction |
5.9% |
| Rash |
5.5% |
| Stillbirth |
5.5% |
| Weight Decreased |
5.1% |
| Death |
4.7% |
| Drug Exposure During Pregnancy |
4.3% |
| Foetal Exposure During Pregnancy |
4.0% |
| Pneumonia |
4.0% |
| Blood Bilirubin Increased |
3.6% |
| Ventricular Septal Defect |
3.6% |
| Arrhythmia |
3.2% |
| Blood Bilirubin Unconjugated Increased |
3.2% |
| Drug Resistance |
3.2% |
| Haemolytic Anaemia |
3.2% |
| Hepatic Enzyme Increased |
3.2% |
| Vomiting |
3.2% |
|
| Secondary |
| Hiv Infection |
72.9% |
| Antiretroviral Therapy |
3.8% |
| Product Used For Unknown Indication |
3.5% |
| Drug Use For Unknown Indication |
3.3% |
| Drug Exposure During Pregnancy |
2.3% |
| Prophylaxis |
2.0% |
| Hypertension |
1.4% |
| Burkitt's Lymphoma |
1.3% |
| Antifungal Prophylaxis |
1.3% |
| Acquired Immunodeficiency Syndrome |
1.2% |
| Depression |
1.2% |
| Tuberculosis |
1.2% |
| Hepatitis C |
0.9% |
| Diabetes Mellitus |
0.8% |
| Pneumocystis Jiroveci Pneumonia |
0.6% |
| Asthma |
0.5% |
| Insomnia |
0.5% |
| Pyrexia |
0.5% |
| Diarrhoea |
0.5% |
| Medical Diet |
0.4% |
|
| Renal Failure Acute |
9.2% |
| Pregnancy |
8.3% |
| Osteonecrosis |
6.9% |
| Vomiting |
6.3% |
| Weight Decreased |
6.1% |
| Umbilical Cord Abnormality |
6.0% |
| Myocardial Infarction |
5.2% |
| Progressive External Ophthalmoplegia |
5.0% |
| Nephrolithiasis |
4.8% |
| Thrombocytopenia |
4.5% |
| Weight Increased |
4.3% |
| Immune Reconstitution Syndrome |
4.1% |
| Pancreatitis |
3.9% |
| Renal Failure |
3.9% |
| Rhabdomyolysis |
3.9% |
| Ventricular Hypertrophy |
3.8% |
| Drug Interaction |
3.6% |
| Premature Labour |
3.5% |
| Abortion Spontaneous |
3.4% |
| Pyrexia |
3.4% |
|
| Concomitant |
| Hiv Infection |
73.0% |
| Drug Use For Unknown Indication |
5.4% |
| Product Used For Unknown Indication |
3.3% |
| Acquired Immunodeficiency Syndrome |
1.9% |
| Hepatitis C |
1.8% |
| Antiretroviral Therapy |
1.7% |
| Depression |
1.4% |
| Prophylaxis |
1.3% |
| Hypertension |
1.3% |
| Drug Exposure During Pregnancy |
1.2% |
| Burkitt's Lymphoma |
1.1% |
| Antifungal Prophylaxis |
0.8% |
| Diabetes Mellitus |
0.8% |
| Hiv Test Positive |
0.8% |
| Pain |
0.8% |
| Pneumocystis Jiroveci Pneumonia |
0.8% |
| Antibiotic Prophylaxis |
0.7% |
| Prophylaxis Against Hiv Infection |
0.7% |
| Diarrhoea |
0.6% |
| Asthma |
0.5% |
|
| Weight Decreased |
10.1% |
| Vomiting |
8.8% |
| Rash |
7.4% |
| Rhabdomyolysis |
6.1% |
| Drug Exposure During Pregnancy |
6.0% |
| Myocardial Infarction |
5.8% |
| Death |
5.2% |
| Renal Failure Acute |
5.2% |
| Thrombocytopenia |
5.1% |
| Pyrexia |
4.5% |
| Nephrolithiasis |
4.3% |
| Renal Failure |
4.0% |
| Renal Tubular Necrosis |
4.0% |
| Pancreatitis |
3.6% |
| Jaundice |
3.4% |
| Premature Baby |
3.4% |
| Small For Dates Baby |
3.4% |
| Abortion Spontaneous |
3.2% |
| Suicidal Ideation |
3.2% |
| Hodgkin's Disease |
3.1% |
|
| Interacting |
| Hiv Infection |
55.3% |
| Antiretroviral Therapy |
14.1% |
| Product Used For Unknown Indication |
7.3% |
| Hypertension |
4.0% |
| Neuropathy Peripheral |
2.8% |
| Anxiety |
1.6% |
| Blood Pressure Increased |
1.5% |
| Depression |
1.5% |
| Immunosuppressant Drug Therapy |
1.5% |
| Alcohol Abuse |
1.4% |
| Back Pain |
1.1% |
| Herpes Simplex |
1.1% |
| Drug Use For Unknown Indication |
1.0% |
| Acquired Immunodeficiency Syndrome |
0.9% |
| Bipolar Disorder |
0.9% |
| Chronic Obstructive Pulmonary Disease |
0.9% |
| Fungal Infection |
0.9% |
| Splenectomy |
0.9% |
| Asthma |
0.8% |
| Colitis |
0.8% |
|
| Drug Interaction |
39.3% |
| Oedema Peripheral |
7.4% |
| Cushing's Syndrome |
4.9% |
| Weight Increased |
4.9% |
| Toxicity To Various Agents |
4.1% |
| Lactic Acidosis |
3.3% |
| Overdose |
3.3% |
| Renal Impairment |
3.3% |
| Secondary Adrenocortical Insufficiency |
3.3% |
| Vision Blurred |
3.3% |
| Drug Level Increased |
2.5% |
| Hepatobiliary Disease |
2.5% |
| Hyperglycaemia |
2.5% |
| Hypothyroidism |
2.5% |
| Renal Tubular Necrosis |
2.5% |
| Sedation |
2.5% |
| Serotonin Syndrome |
2.5% |
| Somnolence |
2.5% |
| Blood Creatinine Increased |
1.6% |
| Hepatitis B |
1.6% |
|
